Conference paper

Binding of organoruthenium anticancer drugs to DNA

Organoruthenium compds. have emerged as promising novel anticancer agents but very little is known about their mol. mechanism of action. Here, we present classical and mixed QM/MM first-principles MD simulations of two ruthenium(II) compds. and their binding to DNA. [on SciFinder (R)]


  • There is no available fulltext. Please contact the lab or the authors.

Related material